Form 8-K - Current report:
SEC Accession No. 0001437749-25-006898
Filing Date
2025-03-11
Accepted
2025-03-11 07:10:00
Documents
18
Period of Report
2025-03-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K opk20250305c_8k.htm   iXBRL 8-K 36111
2 EXHIBIT 2.1 ex_788191.htm EX-2.1 446566
3 EXHIBIT 99.1 ex_785980.htm EX-99.1 13890
8 ex_788191img001.jpg GRAPHIC 988
9 ex_788191img002.jpg GRAPHIC 1066
  Complete submission text file 0001437749-25-006898.txt   739655

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA opk-20250310.xsd EX-101.SCH 3401
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE opk-20250310_def.xml EX-101.DEF 11421
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE opk-20250310_lab.xml EX-101.LAB 15310
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE opk-20250310_pre.xml EX-101.PRE 11581
20 EXTRACTED XBRL INSTANCE DOCUMENT opk20250305c_8k_htm.xml XML 2816
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4181
OPKO HEALTH, INC. (Filer) CIK: 0000944809 (see all company filings)

EIN.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33528 | Film No.: 25725838
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)